Page last updated: 2024-10-30

leflunomide and Cranial Nerve Diseases

leflunomide has been researched along with Cranial Nerve Diseases in 1 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Cranial Nerve Diseases: Disorders of one or more of the twelve cranial nerves. With the exception of the optic and olfactory nerves, this includes disorders of the brain stem nuclei from which the cranial nerves originate or terminate.

Research Excerpts

ExcerptRelevanceReference
"Leflunomide is a new drug for the treatment of rheumatoid arthritis."3.73[Leflunomide-related severe axonal neuropathy]. ( Antoine, JC; Camu, W; Coudeyre, E; Gabelle, A; Hillaire-Buys, D, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gabelle, A1
Antoine, JC1
Hillaire-Buys, D1
Coudeyre, E1
Camu, W1

Other Studies

1 other study available for leflunomide and Cranial Nerve Diseases

ArticleYear
[Leflunomide-related severe axonal neuropathy].
    Revue neurologique, 2005, Volume: 161, Issue:11

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Axons; Cranial Nerve Diseases;

2005